BridgeBio Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-136.6M | $-138.8M | $2.2M | $6.1M |
| FY2019 | $-253.6M | $-256.2M | $2.6M | $21.4M |
| FY2020 | $-399.7M | $-407.2M | $7.5M | $58.5M |
| FY2021 | $-497.9M | $-511.2M | $13.2M | $99.5M |
| FY2022 | $-419.5M | $-424.3M | $4.8M | $91.6M |